(Q46684151)
Statements
1 reference
Vandetanib plus pemetrexed for the second-line treatment of advanced non-small-cell lung cancer: a randomized, double-blind phase III trial (English)
1 reference
1 reference
Richard H de Boer
1 reference
Óscar Arrieta
1 reference
Chih-Hsin Yang
1 reference
Maya Gottfried
1 reference
Valorie Chan
1 reference
Johann Raats
1 reference
Filippo de Marinis
1 reference
Raymond P Abratt
1 reference
Jürgen Wolf
1 reference
Peter Langmuir
1 reference
Tsveta Milenkova
1 reference
Jessica Read
1 reference
Johan F Vansteenkiste
1 reference
31 January 2011
1 reference
29
1 reference
8
1 reference
1067-1074
1 reference